| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
6,405 |
5,591 |
$171K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,066 |
957 |
$161K |
| 87428 |
|
1,921 |
1,836 |
$115K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,759 |
472 |
$76K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,333 |
7,041 |
$69K |
| 84484 |
|
1,914 |
1,595 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,509 |
4,310 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
2,499 |
2,280 |
$53K |
| 36415 |
Collection of venous blood by venipuncture |
3,810 |
3,009 |
$52K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,222 |
2,072 |
$50K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
176 |
167 |
$35K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,226 |
1,865 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,462 |
1,279 |
$33K |
| 80050 |
General health panel |
645 |
608 |
$26K |
| 80306 |
|
1,105 |
998 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
1,817 |
1,633 |
$22K |
| 83880 |
|
906 |
797 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
523 |
500 |
$18K |
| 83605 |
|
772 |
693 |
$18K |
| 83690 |
|
1,029 |
926 |
$14K |
| 80061 |
Lipid panel |
1,577 |
1,497 |
$13K |
| 81025 |
|
1,355 |
1,238 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
136 |
94 |
$13K |
| 83735 |
|
1,279 |
1,121 |
$12K |
| 81003 |
|
2,432 |
2,226 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
167 |
150 |
$10K |
| 81001 |
|
2,243 |
2,023 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,064 |
991 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
186 |
180 |
$9K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
522 |
414 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
864 |
774 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,049 |
987 |
$6K |
| 85610 |
|
1,282 |
1,134 |
$6K |
| 87081 |
|
629 |
599 |
$6K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
78 |
75 |
$5K |
| 87807 |
|
443 |
419 |
$5K |
| 85730 |
|
543 |
493 |
$4K |
| 87400 |
|
330 |
324 |
$4K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
107 |
91 |
$4K |
| 84439 |
|
465 |
432 |
$3K |
| 80164 |
|
493 |
469 |
$3K |
| 73630 |
|
79 |
73 |
$3K |
| 73562 |
|
66 |
63 |
$3K |
| 82962 |
|
210 |
159 |
$2K |
| 71020 |
|
167 |
153 |
$2K |
| 87077 |
|
257 |
228 |
$2K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
52 |
38 |
$2K |
| 87040 |
|
121 |
108 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
25 |
25 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
354 |
273 |
$2K |
| 73610 |
|
80 |
74 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
830 |
732 |
$2K |
| 87186 |
|
235 |
211 |
$1K |
| 87420 |
|
107 |
106 |
$1K |
| 82553 |
|
62 |
58 |
$1K |
| 82550 |
|
87 |
82 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
25 |
25 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
15 |
$1K |
| 87430 |
|
71 |
69 |
$974.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
604 |
541 |
$821.40 |
| 73030 |
|
15 |
14 |
$699.65 |
| 74022 |
|
20 |
12 |
$697.78 |
| 82947 |
|
35 |
25 |
$676.93 |
| 82077 |
|
27 |
26 |
$544.98 |
| 72100 |
|
12 |
12 |
$480.56 |
| 74018 |
|
15 |
15 |
$414.31 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
322 |
301 |
$335.88 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
763 |
685 |
$323.31 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
19 |
14 |
$295.89 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
446 |
395 |
$288.08 |
| 82805 |
|
13 |
13 |
$287.27 |
| 73110 |
|
13 |
13 |
$266.00 |
| 82607 |
|
27 |
26 |
$258.24 |
| 87147 |
|
25 |
24 |
$253.26 |
| 71010 |
|
27 |
27 |
$198.00 |
| 87088 |
|
31 |
26 |
$189.24 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
120 |
103 |
$150.24 |
| 86140 |
|
19 |
13 |
$131.12 |
| 87070 |
|
14 |
13 |
$126.32 |
| 82570 |
|
44 |
39 |
$112.85 |
| 87205 |
|
26 |
25 |
$103.85 |
| 85651 |
|
34 |
27 |
$81.12 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
218 |
193 |
$72.83 |
| 82043 |
|
28 |
27 |
$66.16 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
32 |
29 |
$10.98 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
14 |
$10.85 |
| A9270 |
Non-covered item or service |
97 |
76 |
$7.70 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
14 |
$0.00 |